-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Adaptimmune Therapeutics PLC quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to 2024.
- Adaptimmune Therapeutics PLC Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 1.51B shares, a 25.5% increase year-over-year.
- Adaptimmune Therapeutics PLC annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1.51B shares, a 25.5% increase from 2023.
- Adaptimmune Therapeutics PLC annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.21B shares, a 24.7% increase from 2022.
- Adaptimmune Therapeutics PLC annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 967M shares, a 3.47% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)